glp-1 class drugs Agonists for Weight Loss: Safe or Risky? GLP-1 Drug Comparison in Diabetes

New data shared at ADA 2024 showcase the efficacy across both kidney and CV outcomes, with clear benefit across patient subgroups

this drug has recently completed phase 2a clinical trials with promising results in reducing HbA1c without any nausea [50]

In addition, GLP-1 can slow gastric emptying, reduce appetite in patients and thus reduce body mass, control blood pressure, regulate blood lipids and protect cardiovascular function, and has a low risk of hypoglycemia

Phentermine can also interact with serotonergic drugs or antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and tricyclic antidepressants (TCAs)

Subgroup analysis based on the dosage of drugs could not be done for the same reason mentioned for the follow-up period